24/7 Real-Time Shipment Visibility with CSafe Active Containers

  • Integrated, airline approved telemetry
  • Real-time alerts
  • Standard rest API packet
  • GDP Compliant Standard shipment report

Temperature asssured

Life enhanced

Go to article: Home | Mapping the RNA therapeutics R&D landscape in 2022 Go to article: In this issueGo to article: ContentsGo to article: CSafe GlobalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: HOF SonderanlagenbauGo to article: BEA TechnologiesGo to article: CommentGo to article: Restrictive Medicare coverage spells continued uncertainty for AduhelmGo to article: 2021: a record year for orphan therapiesGo to article: Trikafta/Kaftrio continues to be a game-changer for cystic fibrosis patientsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: In DepthGo to article: Mapping the RNA therapeutics R&D landscape in 2022Go to article: A cloudy day in paradise for pharma tax havens in Cayman Islands & Bermuda?Go to article: Pharmaceutical Technology Excellence Awards 2021 – Winners Announced!Go to article: How technology could transform drug research in 2022Go to article: Anaesthesia drugs worst-hit by US drug shortagesGo to article: Molnar-Institute Company Insight Go to article: Molnar-InstituteGo to article: In DataGo to article: Asia-Pacific sees the largest growth in metabolic disorders-related trials over Go to article: The Middle East has seen the largest growth in infectious disease-related trials over the past decadeGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: BaxterGo to article: EventsGo to article: Next issue